Church & Dwight (CHD) 10-Q1 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2024	Oct. 30, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Trading Symbol	CHD
Entity Registrant Name	CHURCH & DWIGHT CO., INC.
Entity Central Index Key	0000313927
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	1-10585
Entity Tax Identification Number	13-4996950
Entity Address, Address Line One	500 Charles Ewing Boulevard
Entity Address, City or Town	Ewing
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08628
City Area Code	609
Local Phone Number	806-1200
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common Stock, $1 par value
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		244,997,535

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net Sales	$ 1,510.6	$ 1,455.9	$ 4,525.1	$ 4,339.9
Cost of sales	827.5	809.6	2,442.9	2,432.7
Gross Profit	683.1	646.3	2,082.2	1,907.2
Marketing expenses	185.8	167.8	490.2	422.3
Selling, general and administrative expenses	231.7	222.7	684.5	643.6
Tradename and other asset impairments	357.1	0	357.1	0
(Loss) Income from Operations	(91.5)	255.8	550.4	841.3
Equity in earnings of affiliates	3	1.7	7.2	8.1
Interest income	10.6	4.5	17.7	7.2
Interest expense	(23.4)	(27.2)	(71.6)	(83.9)
Other income (expense), net	(0.1)	(0.8)	(0.5)	(0.5)
(Loss) Income before Income Taxes	(101.4)	234	503.2	772.2
Income taxes	(26.3)	56.5	107.1	170.3
Net (Loss) Income	$ (75.1)	$ 177.5	$ 396.1	$ 601.9
Weighted average shares outstanding - Basic	244.6	246	244.1	244.9
Weighted average shares outstanding - Diluted	244.6	248.7	246.7	247.8
Net (loss) income per share - Basic	$ (0.31)	$ 0.72	$ 1.62	$ 2.46
Net (loss) income per share - Diluted	(0.31)	0.71	1.61	2.43
Cash dividends per share	$ 0.28	$ 0.27	$ 0.85	$ 0.82

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (75.1)	$ 177.5	$ 396.1	$ 601.9
Other comprehensive income, net of tax:
Foreign exchange translation adjustments	11.6	(6.4)	5.3	(0.7)
Defined benefit plan adjustments gain (loss)	0	1.3	(0.2)	2.8
Income (loss) from derivative agreements	(0.7)	3.5	3.9	(2.2)
Other comprehensive income (loss)	10.9	(1.6)	9	(0.1)
Comprehensive income	$ (64.2)	$ 175.9	$ 405.1	$ 601.8

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 752.1	$ 344.5
Accounts receivable, less allowances of $7.0 and $7.3	555.3	526.9
Inventories	658.5	613.3
Other current assets	50.8	45
Total Current Assets	2,016.7	1,529.7
Property, Plant and Equipment, Net	915.3	927.7
Equity Investment in Affiliates	12	12
Net Carrying Value Trade Names	2,919.7	3,302.3
Goodwill	2,433.3	2,431.5
Other Assets	369.2	366
Total Assets	8,666.2	8,569.2
Current Liabilities
Short-term borrowings	3.4	3.9
Current portion of long-term debt	0	199.9
Accounts payable	705.9	630.6
Accrued expenses and other liabilities	529.6	580.4
Income taxes payable	7.7	7.2
Total Current Liabilities	1,246.6	1,422
Long-term Debt	2,208.2	2,202.2
Deferred Income Taxes	658.6	743.1
Deferred and Other Long-term Liabilities	326.4	313.7
Business Acquisition Liabilities	32.7	32.8
Total Liabilities	4,472.5	4,713.8
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued	0	0
Common Stock, $1.00 par value, Authorized 600,000,000 shares and 293,709,982 shares issued as of September 30, 2024 and December 31, 2023	293.7	293.7
Additional paid-in capital	534.7	454.8
Retained earnings	6,200.9	6,012.3
Accumulated other comprehensive loss	(18.2)	(27.2)
Common stock in treasury, at cost: 48,777,196 shares as of September 30, 2024 and 50,557,219 shares as of December 31, 2023	(2,817.4)	(2,878.2)
Total Stockholders' Equity	4,193.7	3,855.4
Total Liabilities and Stockholders' Equity	$ 8,666.2	$ 8,569.2

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 7	$ 7.3
Preferred Stock, par value	$ 1	$ 1
Preferred Stock, Authorized	2,500,000	2,500,000
Preferred Stock, issued	0	0
Common Stock, par value	$ 1	$ 1
Common Stock, Authorized	600,000,000	600,000,000
Common Stock, shares issued	293,709,982	293,709,982
Treasury Stock, Shares	48,777,196	50,557,219

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flow From Operating Activities
Net Income (Loss)	$ 396.1	$ 601.9
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	59.8	52.8
Amortization expense	117.6	114.1
Deferred income taxes	(92)	(6)
Tradename and Other Asset Impairments	357.1	0
Equity in net earnings of affiliates	(7.2)	(8.1)
Distributions from unconsolidated affiliates	7.2	7.2
Non-cash compensation expense	50.6	51.5
Other	7.1	1.9
Change in assets and liabilities:
Accounts receivable	(25.9)	(37.4)
Inventories	(35)	(24.5)
Other current assets	4	11.2
Accounts payable	88	(10.1)
Accrued expenses	(42.3)	42.1
Income taxes payable	(5)	9.3
Other operating assets and liabilities, net	(16.2)	(10.8)
Net Cash Provided By Operating Activities	863.9	795.1
Cash Flow From Investing Activities
Additions to property, plant and equipment	(125.2)	(121.5)
Graphico acquisition	(19.9)	0
Proceeds from sale of assets	6.6	0
Other	0.4	(6.9)
Net Cash Used In Investing Activities	(138.1)	(128.4)
Cash Flow From Financing Activities
Long Term debt borrowings	0.4	0
Long-term debt (repayments)	(200.6)	(200)
Short-term debt (repayments), net of borrowings	0	(70.6)
Proceeds from stock options exercised	90.3	107.6
Payment of cash dividends	(207.4)	(199.9)
Deferred financing and other	(1)	(0.1)
Net Cash Used In Financing Activities	(318.3)	(363)
Effect of exchange rate changes on cash and cash equivalents	0.1	(0.7)
Net Change In Cash and Cash Equivalents	407.6	303
Cash and Cash Equivalents at Beginning of Period	344.5	270.3
Cash and Cash Equivalents at End of Period	752.1	573.3
Cash paid during the period for:
Interest (net of amounts capitalized)	62.9	77
Income taxes	204.3	167
Supplemental disclosure of non-cash investing activities:
Property, plant and equipment expenditures included in Accounts Payable	$ 15.9	$ 47.1

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2022	$ 3,489.9	$ 293.7	$ (2,665.3)	$ 366.2	$ 5,524.6	$ (29.3)
Beginning Balance (in shares) at Dec. 31, 2022		293.7	(49.8)
Net income (loss)	203.2	$ 0	$ 0	0	203.2	0
Other comprehensive income (loss)	3.1	0	0	0	0	3.1
Cash dividends	(66.3)	0	0	0	(66.3)	0
Stock based compensation expense and stock option plan transactions	37.8	$ 0	$ 10.3	27.8	(0.3)	0
Stock based compensation expense and stock option plan transactions (in shares)		0	0.3
Ending Balance at Mar. 31, 2023	3,667.7	$ 293.7	$ (2,655)	394	5,661.2	(26.2)
Ending Balance (in shares) at Mar. 31, 2023		293.7	(49.5)
Beginning Balance at Dec. 31, 2022	3,489.9	$ 293.7	$ (2,665.3)	366.2	5,524.6	(29.3)
Beginning Balance (in shares) at Dec. 31, 2022		293.7	(49.8)
Net income (loss)	601.9
Other comprehensive income (loss)	(0.1)
Ending Balance at Sep. 30, 2023	4,050.5	$ 293.7	$ (2,581.1)	441.4	5,925.9	(29.4)
Ending Balance (in shares) at Sep. 30, 2023		293.7	(47.4)
Beginning Balance at Mar. 31, 2023	3,667.7	$ 293.7	$ (2,655)	394	5,661.2	(26.2)
Beginning Balance (in shares) at Mar. 31, 2023		293.7	(49.5)
Net income (loss)	221.2	$ 0	$ 0	0	221.2	0
Other comprehensive income (loss)	(1.6)	0	0	0	0	(1.6)
Cash dividends	(66.7)	0	0	0	(66.7)	0
Stock based compensation expense and stock option plan transactions	90.4	$ 0	$ 62.2	28.6	(0.4)	0
Stock based compensation expense and stock option plan transactions (in shares)		0	1.8
Ending Balance at Jun. 30, 2023	3,911	$ 293.7	$ (2,592.8)	422.6	5,815.3	(27.8)
Ending Balance (in shares) at Jun. 30, 2023		293.7	(47.7)
Net income (loss)	177.5	$ 0	$ 0	0	177.5	0
Other comprehensive income (loss)	(1.6)	0	0	0	0	(1.6)
Cash dividends	(66.9)	0	0	0	(66.9)	0
Stock based compensation expense and stock option plan transactions	30.5	$ 0	$ 11.7	18.8	0	0
Stock based compensation expense and stock option plan transactions (in shares)		0	0.3
Ending Balance at Sep. 30, 2023	4,050.5	$ 293.7	$ (2,581.1)	441.4	5,925.9	(29.4)
Ending Balance (in shares) at Sep. 30, 2023		293.7	(47.4)
Beginning Balance at Dec. 31, 2023	3,855.4	$ 293.7	$ (2,878.2)	454.8	6,012.3	(27.2)
Beginning Balance (in shares) at Dec. 31, 2023		293.7	(50.6)
Net income (loss)	227.7	$ 0	$ 0	0	227.7	0
Other comprehensive income (loss)	(2.1)	0	0	0	0	(2.1)
Cash dividends	(69)	0	0	0	(69)	0
Stock based compensation expense and stock option plan transactions	88.7	$ 0	$ 45.4	43.5	(0.2)	0
Stock based compensation expense and stock option plan transactions (in shares)		0	1.4
Ending Balance at Mar. 31, 2024	4,100.7	$ 293.7	$ (2,832.8)	498.3	6,170.8	(29.3)
Ending Balance (in shares) at Mar. 31, 2024		293.7	(49.2)
Beginning Balance at Dec. 31, 2023	3,855.4	$ 293.7	$ (2,878.2)	454.8	6,012.3	(27.2)
Beginning Balance (in shares) at Dec. 31, 2023		293.7	(50.6)
Net income (loss)	396.1
Other comprehensive income (loss)	9
Ending Balance at Sep. 30, 2024	4,193.7	$ 293.7	$ (2,817.4)	534.7	6,200.9	(18.2)
Ending Balance (in shares) at Sep. 30, 2024		293.7	(48.6)
Beginning Balance at Mar. 31, 2024	4,100.7	$ 293.7	$ (2,832.8)	498.3	6,170.8	(29.3)
Beginning Balance (in shares) at Mar. 31, 2024		293.7	(49.2)
Net income (loss)	243.5	$ 0	$ 0	0	243.5	0
Other comprehensive income (loss)	0.2	0	0	0	0	0.2
Cash dividends	(69.2)	0	0	0	(69.2)	0
Stock based compensation expense and stock option plan transactions	30.3	$ 0	$ 9.8	20.4	0.1	0
Stock based compensation expense and stock option plan transactions (in shares)		0	0.3
Ending Balance at Jun. 30, 2024	4,305.5	$ 293.7	$ (2,823)	518.7	6,345.2	(29.1)
Ending Balance (in shares) at Jun. 30, 2024		293.7	(48.9)
Net income (loss)	(75.1)	$ 0	$ 0	0	(75.1)	0
Other comprehensive income (loss)	10.9	0	0	0	0	10.9
Cash dividends	(69.2)	0	0	0	(69.2)	0
Stock based compensation expense and stock option plan transactions	21.6	$ 0	$ 5.6	16	0	0
Stock based compensation expense and stock option plan transactions (in shares)		0	0.3
Ending Balance at Sep. 30, 2024	$ 4,193.7	$ 293.7	$ (2,817.4)	$ 534.7	$ 6,200.9	$ (18.2)
Ending Balance (in shares) at Sep. 30, 2024		293.7	(48.6)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (75.1)	$ 243.5	$ 227.7	$ 177.5	$ 221.2	$ 203.2	$ 396.1	$ 601.9

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation These condensed consolidated financial statements have been prepared by Church & Dwight Co., Inc. (the “Company”). In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations and cash flows for all periods presented have been made. Results of operations for interim periods may not be representative of results to be expected for the full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”). The Company incurred research and development expenses in the third quarter of 2024 and 2023 of $ 36.0 and $ 30.3 , respectively. The Company incurred research and development expenses in the first nine months of 2024 and 2023 of $ 99.1 and $ 87.2 , respectively. These expenses are included in selling, general and administrative (“SG&A”) expenses.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
New Accounting Pronouncements	Sep. 30, 2024
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	2. New Accounting Pronouncements Recently Adopted Accounting Pronouncements In September 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update (“ASU”) 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50): Disclosure of Supplier Finance Program Obligations, intended to add certain qualitative and quantitative disclosure requirements for a buyer in a supplier finance program. The amendments require a buyer that uses supplier finance programs to make annual disclosures about the program’s key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period, and associated rollforward information. Only the amount outstanding at the end of the period must be disclosed in interim periods. The amendments are effective for all entities for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the requirement to disclose rollforward information, which is effective prospectively for fiscal years beginning after December 15, 2023. The Company adopted the standard on January 1, 2023 which resulted in additional disclosures. Refer to Note 13. Recent Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption on our consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosure which includes amendments that further expand income tax disclosures, by requiring the disaggregation of information in the rate reconciliation table, and income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and are to be applied either prospectively or retrospectively. The Company is currently evaluating the impact of adoption on the Company’s related disclosures. There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

Inventories

Inventories	9 Months Ended
Inventories	Sep. 30, 2024
Inventory Disclosure [Abstract]
Inventories	3. Inventories Inventories consist of the following: September 30, December 31, 2024 2023 Raw materials and supplies $ 140.6 $ 137.5 Work in process 51.5 40.2 Finished goods 466.4 435.6 Total $ 658.5 $ 613.3

Property, Plant and Equipment,

Property, Plant and Equipment, Net ("PP&E")	9 Months Ended
Property, Plant and Equipment, Net ("PP&E")	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net ("PP&E")	4. Property, Plant and Equipment, Net (“PP&E”) PP&E consists of the following: September 30, December 31, 2024 2023 Land $ 28.3 $ 28.3 Buildings and improvements 346.2 317.8 Machinery and equipment 987.8 895.1 Software 128.1 122.6 Office equipment and other assets 125.3 105.2 Construction in progress (1) 213.8 348.4 Gross PP&E 1,829.5 1,817.4 Less accumulated depreciation 914.2 889.7 Net PP&E $ 915.3 $ 927.7 (1) In connection with the Vitamins, Minerals and Supplements ("VMS") impairment review completed in the third quarter of 2024, the Company recorded an impairment charge of $ 60.0 in SG&A of Construction in progress assets. The charge was recorded in the Consumer Domestic segment. Refer to Note 11 for additional details. Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Depreciation expense on PP&E $ 21.0 $ 18.2 $ 59.8 $ 52.8

Earnings Per Share ("EPS")

Earnings Per Share ("EPS")	9 Months Ended
Earnings Per Share ("EPS")	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share ("EPS")	5. Earnings Per Share (“EPS”) Basic EPS is calculated based on income (loss) available to holders of the Company’s common stock (“Common Stock”) and the weighted average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the Company's stock-based compensation plans. The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Weighted average common shares outstanding - basic 244.6 246.0 244.1 244.9 Dilutive effect of stock options 0.0 (1) 2.7 2.6 2.9 Weighted average common shares outstanding - diluted 244.6 248.7 246.7 247.8 Antidilutive stock options outstanding 1.1 2.5 1.1 2.6 (1) Due to the net loss during the three months ended September 30, 2024, there was no dilutive effect of stock options because the impact would be antidilutive.

Stock Based Compensation Plans

Stock Based Compensation Plans	9 Months Ended
Stock Based Compensation Plans	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation Plans	6. Stock Based Com pensation Plans In the first quarter of 2023, the Company updated its Long-Term Incentive Program (“LTIP”) to provide employees with an award of stock options and initial grants of restricted stock units (“RSUs”), and made an initial grant of performance share units ("PSUs") to members of the Company's Executive Leadership Team ("ELT"). In connection with this update, the awards are now granted in the first quarter of each year. Prior to 2023, the awards were granted in the second quarter. The Company recognizes the grant-date fair value for each of these awards, less estimated forfeitures, as compensation expense ratably over the vesting period. For employees and directors that meet retirement eligibility requirements, the expense related to share-based compensation is recognized on the date of grant as there is no future service period required for the awards to vest. Stock Options The following table provides a summary of option activity: Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Term Intrinsic Options Price (per share) (in Years) Value Outstanding at December 31, 2023 10.2 $ 68.77 Granted 1.0 100.43 Exercised ( 1.7 ) 52.40 Cancelled ( 0.1 ) 86.15 Outstanding at September 30, 2024 9.4 $ 75.03 6.0 $ 281.4 Exercisable at September 30, 2024 6.0 $ 66.78 4.6 $ 226.9 The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Intrinsic Value of Stock Options Exercised $ 5.3 $ 14.2 $ 86.6 $ 121.9 Stock Compensation Expense Related to Stock Option Awards $ 4.3 $ 3.8 $ 24.8 $ 22.7 Issued Stock Options 0.0 0.0 1.0 1.0 Weighted Average Fair Value of Stock Options issued (per share) $ 0.0 $ 0.0 $ 29.90 $ 24.05 Fair Value of Stock Options Issued $ 0.0 $ 0.0 $ 31.1 $ 24.8 The following table provides a summary of the assumptions used in the valuation of issued stock options: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Risk-free interest rate N/A N/A 4.2 % 4.0 % Expected life in years N/A N/A 7.2 7.3 Expected volatility N/A N/A 22.3 % 22.4 % Dividend yield N/A N/A 1.1 % 1.3 % Restricted Stock Units The Company granted employees 105,600 RSUs with a total fair value of $ 10.8 at a weighted average grant date fair value of $ 101.93 per RSU during the nine months ended September 30, 2024 and granted employees 119,570 RSUs with a total fair value of $ 10.3 at a weighted average grant date fair value of $ 86.18 per RSU during the nine months ended September 30, 2023. The annual RSU grants vest one-third on each of the first, second and third anniversaries of the grant date, subject to the recipient’s continued employment with the Company from the grant date through the applicable vesting date, and are settled with shares of the Company’s Common Stock within 60 days following the applicable vesting date. Additionally, in connection with the Hero Acquisition (see Note 10), 854,882 shares of restricted stock were issued to certain individuals in October 2022 with a total fair value of $ 61.5 . This restricted stock is recognized as compensation expense ratably over the vesting period if those individuals continue to be employed by the Company. The vesting requirements are satisfied at various dates over a three-year period from the date of the acquisition. 213,719 shares have vested as of September 30,2024 with an additional 213,719 vesting in October 2024. T he restricted stock expense associated with the Hero Acquisition for the nine months ended September 30, 2024 and 2023 was $ 17.2 and $ 21.9 , respectively, and is included in the Non-cash compensation expense caption in the condensed consolidated statement of cash flows. Performance Stock Units In the first quarter of 2024 and 2023, the Company granted PSUs to members of the Executive Leadership Team including the CEO, with an aggregate award equal to 19,960 and 19,650 PSUs, respectively. The PSUs were valued at a weighted average grant date fair value per PSU equal to $ 122.24 in 2024 and $ 110.95 in 2023 using a Monte Carlo model. The performance target is based on the Company's total shareholder return ("TSR") relative to a Company-selected peer group. The PSUs vest on the later of (i) the third anniversary of the grant date, and (ii) the date that the Board's Compensation & Human Capital Committee certifies the achievement of the applicable performance goals, in each case, subject to the recipient’s continued employment with the Company from the grant date through the vesting date. The number of shares that may be issued ranges from 0 % to 200 % based on relative TSR during the three-year performance period.

Share Repurchases

Share Repurchases	9 Months Ended
Share Repurchases	Sep. 30, 2024
Payments for Repurchase of Equity [Abstract]
Share Repurchases	7. Share Repur chases On October 28, 2021, the Board authorized the Company's share repurchase program, under which the Company may repurchase up to $ 1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase Program does not have an expiration and replaced the 2017 Share Repurchase Program. The 2021 Share Repurchase Program did not modify the Company’s evergreen share repurchase program, authorized by the Board on January 29, 2014, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under its incentive plans. As of September 30, 2024, there remains $ 658.9 of share repurchase availability under the 2021 Share Repurchase Program.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	8. Fair Value Meas urements The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 Input Carrying Fair Carrying Fair Level Amount Value Amount Value Financial Assets: Cash equivalents Level 1 $ 571.9 $ 571.9 $ 217.7 $ 217.7 Financial Liabilities: Short-term borrowings Level 2 3.4 3.4 3.9 3.9 Term loan due December 22, 2024 Level 2 0.0 0.0 200.0 200.0 3.15 % Senior notes due August 1, 2027 Level 2 424.9 415.1 424.8 406.9 2.3 % Senior notes due December 15, 2031 Level 2 399.4 348.8 399.3 338.6 5.6 % Senior notes due November 15, 2032 Level 2 499.2 537.4 499.2 535.6 3.95 % Senior notes due August 1, 2047 Level 2 397.8 333.8 397.7 333.7 5.00 % Senior notes due June 15, 2052 Level 2 499.8 491.3 499.8 498.1 International long-term debt Level 2 4.2 4.2 0.0 0.0 The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the nine months ended September 30, 2024 and 2023. Refer to Note 2 in the Form 10-K for a description of the methods and assumptions used to estimate the fair value of each class of financial instruments reflected in the condensed consolidated balance sheets. The carrying amounts of Accounts Receivable, Accounts Payable, and Accrued and Other Liabilities, approximated estimated fair values as of September 30, 2024 and December 31, 2023 .

Derivative Instruments and Risk

Derivative Instruments and Risk Management	9 Months Ended
Derivative Instruments and Risk Management	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Risk Management	9. Derivative Instruments and Risk Management Changes in interest rates, foreign exchange rates, the price of the Company's Common Stock and commodity prices expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such as cash flow and fair value hedges, diesel and commodity hedge contracts, equity derivatives and foreign exchange forward contracts. The Company does not use derivatives for trading or speculative purposes. Refer to Note 3 in the Form 10-K for a discussion of each of the Company’s derivative instruments in effect as of December 31, 2023. The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table: Notional Notional Amount Amount September 30, 2024 December 31, 2023 Derivatives designated as hedging instruments Foreign exchange contracts $ 219.7 $ 228.9 Diesel fuel contracts 1.9 gallons 2.3 gallons Commodities contracts 10.4 pounds 59.0 pounds Derivatives not designated as hedging instruments Foreign exchange contracts $ 0.3 $ 0.0 Equity derivatives $ 24.5 $ 23.2 The fair values and amount of gain (loss) recognized in income (loss) and Other Comprehensive Income (“OCI”) associated with the derivative instruments disclosed above did not have a material impact on the Company’s condensed consolidated financial statements during the three and nine months ended September 30, 2024.

Acquisitions

Acquisitions	9 Months Ended
Acquisitions	Sep. 30, 2024
Business Combinations [Abstract]
Acquisitions	10. Acquisition s On June 3, 2024, the Company acquired substantially all of the issued and outstanding shares of capital stock of Graphico, Inc. ("Graphico"), a Japan-based distributor focused on consumer goods primarily in the Japanese market (the “Graphico Acquisition”). The Company paid $ 19.9 , net of cash acquired, at closing. The Company acquired the remaining minority shares for approximately $ 2.0 in July 2024. Graphico’s annual net sales for the year ended December 31, 2023 were approximately $ 38.0 . The Graphico Acquisition was financed with cash on hand, is expected to contribute to greater expansion of our business in the Asia-Pacific (APAC) region, and is managed in the Consumer International segment. The preliminary fair values of the net assets at acquisition are set forth as follows: Accounts receivable $ 3.5 Inventory 11.3 Other current assets 1.5 Other long-term assets 5.8 Customer relationship intangible asset 8.4 Goodwill 2.8 Accounts payable, accrued and other liabilities ( 6.9 ) Long-term debt ( 4.4 ) Deferred income taxes ( 2.1 ) Cash purchase price (net of cash acquired) $ 19.9 The customer relationship intangible asset was valued using a discounted cash flow model and has a useful life of 15 years . The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Graphico Acquisition are not deductible for U.S. tax purposes. On October 13, 2022, the Company acquired all of the issued and outstanding shares of capital stock of Hero Cosmetics, Inc. ("Hero"), the developer of the HERO® brand which includes the MIGHTY PATCH® acne treatment products (the “Hero Acquisition”). The Company paid $ 546.8 , net of cash acquired, at closing, and deferred an additional cash payment of $ 8.0 for five years to satisfy certain indemnification obligations, if necessary. The Company also issued $ 61.5 of restricted stock which will be recognized as compensation expense as the vesting requirements for individuals who received the restricted stock, and will continue to be employed by the Company, are satisfied at various dates over a three-year period from the date of the acquisition . 213,719 shares have vested a s of September 30,2024 with an additional 213,719 vesting in October 2024. Hero’s annual net sales for the year ended December 31, 2022 were approximately $ 179.0 . The Hero Acquisition was financed with cash on hand and comme rcial paper borrowings and is managed in the Consumer Domestic segment. In the first quarter of 2023, the Company made a net cash payment of $ 3.5 primarily associated with final working capital adjustments. The fair values of the net assets at acquisition are set forth as follows: Accounts receivable $ 19.5 Inventory 25.4 Other current assets 1.2 Property, plant and equipment 0.4 Trade name 400.0 Other intangible assets 71.9 Goodwill 156.1 Accounts payable, accrued and other liabilities ( 1.1 ) Deferred and other long-term liabilities ( 1.4 ) Deferred income taxes ( 117.2 ) Business acquisition liabilities - long-term ( 8.0 ) Cash purchase price (net of cash acquired) $ 546.8 The trade name and other intangible assets were valued using a discounted cash flow model. The trade name and other intangible assets recognized from the Hero Acquisition have useful lives which range from 10 - 20 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Hero Acquisition are not deductible for U.S. tax purposes.

Goodwill and Other Intangibles,

Goodwill and Other Intangibles, Net	9 Months Ended
Goodwill and Other Intangibles, Net	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangibles, Net	11. Goodwill and Other Intangibles, Net The Company has intangible assets of substantial value on its condensed consolidated balance sheet. These intangible assets are generally related to intangible assets with a definite life, indefinite-lived trade names and goodwill. The Company determines whether an intangible asset (other than goodwill) has a definite life based on multiple factors, including how long the Company intends to generate cash flows from the asset. These intangible assets are more fully explained in the following sections. Intangible Assets With a Definite Life The following table provides information related to the carrying value of intangible assets with a definite life: September 30, 2024 December 31, 2023 Gross Amortization Gross Carrying Accumulated Period Carrying Accumulated Amount Amortization Impairments (1) Net (Years) Amount Amortization Impairments Net Intangible assets with a definite life: Trade Names $ 1,384.5 $ ( 461.2 ) $ 0.0 $ 923.3 3 - 20 $ 1,385.5 $ ( 403.5 ) $ 0.0 $ 982.0 Customer Relationships 645.6 ( 395.2 ) ( 15.8 ) 234.6 15 - 20 644.9 ( 373.3 ) ( 3.5 ) 268.1 Patents/Formulas 205.6 ( 124.2 ) 0.0 81.4 4 - 20 208.3 ( 116.1 ) ( 1.9 ) 90.3 Total $ 2,235.7 $ ( 980.6 ) $ ( 15.8 ) $ 1,239.3 $ 2,238.7 $ ( 892.9 ) $ ( 5.4 ) $ 1,340.4 (1) Intangible asset impairment of VMS customer relationships. See Indefinite-Lived Trade Names disclosure for more info rmation. Intangible amortization expense was $ 30.7 and $ 31.1 for the third quarter of 2024 and 2023, respectively. Intangible amortization expense amounted to $ 92.2 and $ 93.3 for the first nine months of 2024 and 2023, respectively. The Company estimates that intangible amortization expense will be approximately $ 117.0 in 2024 and approximately $ 116.0 declining to $ 88.0 annually over the next five years. Indefinite-Lived Trade Names The following table presents the carrying value of indefinite-lived trade names : September 30, December 31, 2024 2023 Gross Carrying Value Trade Names $ 1,961.7 $ 1,961.9 VMS impairment 281.3 0.0 Net Carrying Value Trade Names $ 1,680.4 $ 1,961.9 The Company’s indefinite-lived trade name impairment review is completed in the fourth quarter of each year. Fair value of indefinite-lived trade names was estimated based on a “relief from royalty” or “excess earnings” discounted cash flow method, which contains numerous variables that are subject to change as business conditions change, and therefore could impact fair values in the future. The key assumptions used in determining fair value are sales growth, profitability margins, tax rates, discount rates and royalty rates. The Company determined that the fair value of all indefinite-lived trade names for each of the years in the three-year period ended December 31, 2023 exceeded their respective carrying values based upon the forecasted cash flows and profitability. During the third quarter of 2024, the Company continued to experience a decline in market share and a deterioration in the financial performance of its Vitamins, Minerals and Supplements ("VMS") business, which includes the VITAFUSION and L'IL CRITTERS tradename, primarily due to significant product competition coming from new category entrants, including private label. The continued decline in profitability has caused management to reassess its long-term strategy and financial outlook of the business. The revised financial outlook reflects lower estimates of future sales growth and cash flows resulting in a triggering event in the third quarter. The triggering event requires the Company to review the carrying value of assets supporting the business. The assets supporting the VMS business include the VITAFUSION and L'IL CRITTERS indefinite-lived trade name, a definite-lived customer relationship intangible asset and PP&E specific to the VMS business. The Company used an excess earnings discounted cash flow model to determine the fair value of the trade name. The assumptions used in the model require significant judgement in determining the expected future cash flows. The key assumptions utilized in the Company's impairment analysis included, but were not limited, net sales growth rates between -15.2% and 2.1%, EBITA margins in the low single digits, and a discount rate of 8.25 %. Estimates are based on market conditions and management’s current expectation of the success of growth and profitability initiatives. The valuation resulted in a full impairment of the $ 281.3 tradename. The remaining carry value of the tradename at September 30, 2024 is $ 0.0 . The Company also evaluated its ability to recover the carrying value of long-lived assets supporting the VMS business by comparing the carrying amount of those assets to the future undiscounted cash flows over the estimated life of the identified primary asset. The result of this evaluation was that the cash flows would not be sufficient to recover the carrying value of the assets requiring the Company to compare the carrying value of those assets to their fair value. The Company used an excess earnings discounted cash flow model to determine the estimated fair value of the long-lived assets. The key assumptions utilized in the Company's impairment analysis included, but were not limited, net sales growth rates between -15.2% and 2.1%, EBITA margins in the low single digits, and a discount rate of 8.25 %. The valuation resulted in a fair value of the long-lived assets that is below their carry value requiring a pre-tax impairment charge of $ 75.8 . The impairment charge was allocated $ 60.0 to the PP&E of the VMS business and $ 15.8 to the remaining customer relationship intangible asset. The remaining carrying values of the PP&E and the customer relationship intangible asset specific to the VMS business at September 30, 2024 are $ 140.0 and $ 0.0 , respectively. A summary of the VMS intangible and fixed asset impairment charges are as follows: September 30, 2024 Trade Name $ 281.3 Customer Relationship Intangible Asset 15.8 PP&E 60.0 Total VMS impairment charges $ 357.1 The Company’s global WATERPIK business has continued to experience a significant decline in customer demand for many of its products, primarily due to lower consumer spending for discretionary products from inflation and a growing number of water flosser consumers switching to more value-branded products. As a result, the WATERPIK business has experienced declining sales and profits resulting in a reduction in expected future cash flows which have eroded a substantial portion of the excess between the fair and carrying value of the trade name. This indefinite-lived intangible asset may be susceptible to impairment and a continued decline in fair value could trigger a future impairment charge of the WATERPIK trade name. The carrying value of the WATERPIK trade name was $ 644.7 and fair value represented 109 % of the carrying value as of October 1, 2023 (the date of the Company's last annual impairment test). The key assumptions used in the projections from the Company’s October 1, 2023 impairment analysis include a discount rate of 8.8 %, revenue growth rates between 0% and 4.5% and EBITA margins between 19% and 26%. These assumptions were based on current market conditions as of the date of the impairment analysis, recent trends and management’s expectation of the success of initiatives to lower costs and to develop lower-cost water flosser alternatives as well as improvement in the supply chain. While management has implemented strategies to address the risk, significant changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair value. Due to the results of the Company's annual impairment test of the WATERPIK trade name, the Company monitors the performance of this business on at least a quarterly basis. Based on that review, the Company's expectations regarding the profitability of the global WATERPIK business has not substantially changed since the Company's last impairment test. Goodwill The carrying amount of goodwill is as follows: Consumer Consumer Specialty Domestic International Products Total Balance at December 31, 2023 $ 2,061.1 $ 234.4 $ 136.0 $ 2,431.5 Graphico acquired goodwill 0.0 $ 2.8 0.0 2.8 Passport divestiture 0.0 0.0 ( 1.0 ) ( 1.0 ) Balance at September 30, 2024 $ 2,061.1 $ 237.2 $ 135.0 $ 2,433.3 The result of the Company’s annual goodwill impairment test, performed in the second quarter of each year, determined that the estimated fair value substantially exceeded the carrying values of all reporting units. The determination of fair value contains numerous variables that are subject to change as business conditions change and therefore could impact fair value in the future.

Leases

Leases	9 Months Ended
Leases	Sep. 30, 2024
Leases [Abstract]
Leases	12. Leases The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment. Leases with an initial term of twelve months or less are not recorded on the condensed consolidated balance sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. For leases beginning in 2019, lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A summary of the Company’s lease information is as follows: September 30, December 31, Classification 2024 2023 Assets Right of use assets Other Assets $ 182.8 $ 186.0 Liabilities Current lease liabilities Accrued and Other Liabilities $ 30.4 $ 24.7 Long-term lease liabilities Deferred and Other Long-term Liabilities 170.9 174.9 Total lease liabilities $ 201.3 $ 199.6 Other information Weighted-average remaining lease term (years) 7.7 8.1 Weighted-average discount rate 4.6 % 4.5 % Three Months Three Months Nine Months Nine Months Ended Ended Ended Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Statement of (Loss) Income Lease cost (1) $ 10.0 $ 7.9 $ 29.8 $ 23.5 Other information Leased assets obtained in exchange for new lease liabilities net of modifications (2) $ 1.2 $ 2.2 $ 19.6 $ 7.3 Cash paid for amounts included in the measurement of lease liabilities $ 8.7 $ 7.6 $ 25.0 $ 23.1 (1) Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first nine months of 2024 and 2023 wa s $ 22.8 and $ 17.9 , respectively, and is included in the Amortization caption in the condensed consolidated statement of cash flo ws. (2) In January 2024, the Company expanded space at one of its leased manufacturing facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $ 15.4 recorded in the first quarter of 2024. The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows: Operating Leases 2024 $ 9.8 2025 38.4 2026 30.0 2027 28.1 2028 25.5 2029 and thereafter 109.4 Total future minimum lease commitments 241.2 Less: Imputed interest ( 39.9 ) Present value of lease liabilities $ 201.3

Accounts Payable, Accrued and O

Accounts Payable, Accrued and Other Liabilities	9 Months Ended
Accounts Payable, Accrued and Other Liabilities	Sep. 30, 2024
Payables and Accruals [Abstract]
Accounts Payable, Accrued and Other Liabilities	13. Accounts Payable, Accrued and Other Liabilities Accounts payable, accrued and other liabilities consist of the following: September 30, December 31, 2024 2023 Accounts payable $ 705.9 $ 630.6 Accrued marketing and promotion costs 249.5 276.7 Accrued wages and related benefit costs 116.5 152.3 Other accrued current liabilities 163.6 151.4 Total $ 1,235.5 $ 1,211.0 In 2015, the Company initiated a Supply Chain Finance program (“SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company for early payment. Participating suppliers negotiate their receivables sales arrangements directly with a third party. The Company is not party to those agreements and do not have an economic interest in the suppliers' decisions to sell their receivables and has not been required to pledge any assets as security nor to provide any guarantee to third-party finance providers or intermediaries. The SCF Program may allow suppliers to obtain more favorable terms than they could secure on their own. The terms of the Company's payment obligations are not impacted by a supplier’s participation in the SCF Program. The Company's payment terms with suppliers are consistent between suppliers that elect to participate in the SCF Program and those that do not participate. As a result, the program does not have an impact to the Company's average days of payables outstanding. As of September 30, 2024, the obligations outstanding related to the SCF program amount to $ 86.5 , recorded within Accounts Payable in the condensed consolidated balance sheets and $ 292.3 payments included in operating activities within the Company's Condensed Consolidated Statements of Cash Flows.

Short-Term Borrowings and Long-

Short-Term Borrowings and Long-Term Debt	9 Months Ended
Short-Term Borrowings and Long-Term Debt	Sep. 30, 2024
Debt Disclosure [Abstract]
Short-Term Borrowings and Long-Term Debt	14. Short-Term Borrowings and Long-Term Debt Short-term borrowings and long-term debt consist of the following: September 30, December 31, 2024 2023 Short-term borrowings Various debt due to international banks 3.4 3.9 Total short-term borrowings $ 3.4 $ 3.9 Long-term debt Term loan due December 22, 2024 $ 0.0 $ 200.0 3.15 % Senior notes due August 1, 2027 425.0 425.0 Less: Discount ( 0.1 ) ( 0.2 ) 2.3 % Senior notes due December 15, 2031 400.0 400.0 Less: Discount ( 0.6 ) ( 0.7 ) 5.6 % Senior notes due November 15, 2032 500.0 500.0 Less: Discount ( 0.8 ) ( 0.8 ) 3.95 % Senior notes due August 1, 2047 400.0 400.0 Less: Discount ( 2.2 ) ( 2.3 ) 5.00 % Senior notes due June 15, 2052 500.0 500.0 Less: Discount ( 0.2 ) ( 0.2 ) Various debt due to international banks 4.2 0.0 Debt issuance costs, net ( 17.1 ) ( 18.7 ) Total long-term debt 2,208.2 2,402.1 Less: Current maturities 0.0 ( 199.9 ) Net long-term debt $ 2,208.2 $ 2,202.2

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	9 Months Ended
Accumulated Other Comprehensive (Loss) Income	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive (Loss) Income	15. Accumulated Other Comprehensive (Loss) Income The components of changes in accumulated other comprehensive (loss) income are as follows: Accumulated Foreign Defined Other Currency Benefit Derivative Comprehensive Adjustments Plans Agreements Income (Loss) Balance at December 31, 2022 $ ( 46.4 ) $ 1.7 $ 15.4 $ ( 29.3 ) Other comprehensive (loss) income before reclassifications ( 0.7 ) 3.8 2.2 5.3 Amounts reclassified to condensed consolidated statement of (a) (b) 0.0 0.0 ( 5.0 ) ( 5.0 ) Tax benefit (expense) 0.0 ( 1.0 ) 0.6 ( 0.4 ) Other comprehensive (loss) income ( 0.7 ) 2.8 ( 2.2 ) ( 0.1 ) Balance at September 30, 2023 $ ( 47.1 ) $ 4.5 $ 13.2 $ ( 29.4 ) Balance at December 31, 2023 $ ( 37.8 ) $ 4.6 $ 6.0 $ ( 27.2 ) Other comprehensive income (loss) before reclassifications 5.3 ( 0.2 ) 7.3 12.4 Amounts reclassified to condensed consolidated statement of (a) (b) 0.0 0.0 ( 1.6 ) ( 1.6 ) Tax benefit (expense) 0.0 0.0 ( 1.8 ) ( 1.8 ) Other comprehensive (loss) income 5.3 ( 0.2 ) 3.9 9.0 Balance at September 30, 2024 $ ( 32.5 ) $ 4.4 $ 9.9 $ ( 18.2 ) (a) Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense. The Company reclassified a gain of $ 0.6 a nd a gain of $ 1.3 to the condensed consolidated statements of (loss) income during the three months ended September 30, 2024 and 2023, respectively.

Commitments, Contingencies and

Commitments, Contingencies and Guarantees	9 Months Ended
Commitments, Contingencies and Guarantees	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments, Contingencies and Guarantees	16. Commitments, Contingencies and Guarantees Commitments a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. The Company is not engaged in any other material transactions with the partnership or the partner supplier. b. As of September 30, 2024 , the Company had commitments of approximately $ 408.6 . These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements. c. As of September 30, 2024, the Company had various guarantees and letters of credit totaling $ 6.0 . d. In connection with the December 1, 2020 acquisition of the ZICAM ® brand (the " Zicam Acquisition"), the Company deferred an additional cash payment of $ 20.0 related to certain indemnifications provided by the seller. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable five years from the closing. In connection with the December 24, 2021 TheraBreath Acquisition, the Company deferred an additional cash payment of $ 14.0 related to certain indemnity obligations provided by the seller. The additional amount, to the extent not used or withheld in satisfaction of such indemnity obligations, is payable in installments between two and four years from the closing, with the first installment payment of $ 2.0 paid in January 2024, an additional $ 7.0 to be paid in December 2024 and the remaining $ 5.0 to be paid in December 2025. In connection with the October 13, 2022 Hero Acquisition, the Company deferred an additional cash payment of $ 8.0 to satisfy certain indemnification obligations. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable five years from the closing. Legal proceedings e. In addition in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations and cash flows. f. In addition to the matters described above, from time to time in the ordinary course of its business the Company is the subject of, or party to, various pending or threatened legal, regulatory or governmental actions or other proceedings, including, without limitation, those relating to, intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety and other compliance related matters. Such proceedings are generally subject to considerable uncertainty and their outcomes, and any related damages, may not be reasonably predictable or estimable. Any such proceedings could result in a material adverse outcome negatively impacting the Company’s business, financial condition, results of operations or cash flows.

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	17. Related Party Transactions The following summarizes the balances and transactions between the Company and Armand Products Company (“Armand”) and the ArmaKleen Company (“ArmaKleen”). The Company held a 50 % ownership interest as of September 30, 2024 in each: Armand ArmaKleen (2) Nine Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Purchases by the Company $ 10.6 $ 11.7 $ 0.0 $ 0.0 Sales by the Company $ 0.0 $ 0.0 $ 1.0 $ 1.1 Outstanding Accounts Receivable $ 0.5 $ 0.6 $ 0.7 $ 0.7 Outstanding Accounts Payable $ 0.9 $ 1.3 $ 0.0 $ 0.0 Administration & Management Oversight Services (1) $ 1.7 $ 1.7 $ 1.6 $ 1.6 (1) Billed by the Company and recorded as a reduction of SG&A expenses . (2) In October 2024, the Company sold its 50 % interest in Armakleen to an unrelated third party. The transaction is not material to the Company's results of operations or cash flows.

Segments

Segments	9 Months Ended
Segments	Sep. 30, 2024
Segment Reporting [Abstract]
Segments	18. Segments Segment Information The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division. These segments are determined based on differences in the nature of products and organizational structure. The Company also has a Corporate segment. Segment revenues are derived from the sale of the following products: Segment Products Consumer Domestic Household and personal care products Consumer International Primarily personal care products SPD Specialty chemical products The Corporate segment income consists of equity in earnings of affiliates. As of September 30, 2024 , the Company held 50 % ownership interests in each of Armand and ArmaKleen, respectively . The Company’s equity in earnings of Armand and ArmaKleen, totaling $ 3.0 and $ 1.7 for the three months ended September 30, 2024 and 2023, respectively, and $ 7.2 and $ 8.1 for the nine months ended September 30, 2024 and 2023, respectively, are included in the Corporate segment. In October 2024, the Company sold its 50 % interest in Armakleen to an unrelated third party. The transaction is not material to the Company’s results of operations or cash flows. Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth in the table below. Segment net sales and income (loss) before income taxes are as follows: Consumer Consumer Domestic International SPD Corporate (3) Total Net Sales (1) Third Quarter 2024 $ 1,170.8 $ 267.7 $ 72.1 $ 0.0 $ 1,510.6 Third Quarter 2023 1,133.1 244.4 78.4 0.0 1,455.9 First Nine Months of 2024 $ 3,506.6 $ 786.4 $ 232.1 $ 0.0 $ 4,525.1 First Nine Months of 2023 3,378.2 716.9 244.8 0.0 4,339.9 (Loss) Income before Income Taxes (2) Third Quarter 2024 (4) $ ( 107.1 ) $ ( 4.7 ) $ 7.4 $ 3.0 $ ( 101.4 ) Third Quarter 2023 203.4 22.7 6.2 1.7 234.0 First Nine Months of 2024 (4) $ 405.3 $ 61.2 $ 29.5 $ 7.2 $ 503.2 First Nine Months of 2023 662.8 79.1 22.2 8.1 772.2 (1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $ 7.0 and $ 4.7 for the three months ended September 30, 2024 and September 30, 2023, respectively, and were $ 19.6 and $ 11.7 for the nine months ended September 30, 2024 and September 30, 2023, respectively. (2) In determining income (loss) before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income (loss) from operations. (3) The Corporate segment consists of equity in earnings of affiliates from Armand and ArmaKleen for the three and nine months ended Sep tember 30, 2024 and September 30, 2023. The Company's 50 % interest in Armakleen was sold to an unrelated third party in October of 2024. The transaction is not material to the Company’s results of operations or cash flows. (4) In the third quarter and first nine months of 2024, the results include the VMS non-cash intangible and PP&E impairment charges of $ 357.1 in SG&A expenses, of which $ 327.4 was recorded in the Consumer Domestic segment and $ 29.7 was recorded in the Consumer International seg ment. Product line revenues from external customers are as follows: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Household Products $ 637.4 $ 636.2 $ 1,929.5 $ 1,857.0 Personal Care Products 533.4 496.9 1,577.1 1,521.2 Total Consumer Domestic 1,170.8 1,133.1 3,506.6 3,378.2 Total Consumer International 267.7 244.4 786.4 716.9 Total SPD 72.1 78.4 232.1 244.8 Total Consolidated Net Sales $ 1,510.6 $ 1,455.9 $ 4,525.1 $ 4,339.9 Household Products include laundry, deodorizing and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products, cold and remedy products, and gummy dietary supplements.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In September 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update (“ASU”) 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50): Disclosure of Supplier Finance Program Obligations, intended to add certain qualitative and quantitative disclosure requirements for a buyer in a supplier finance program. The amendments require a buyer that uses supplier finance programs to make annual disclosures about the program’s key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period, and associated rollforward information. Only the amount outstanding at the end of the period must be disclosed in interim periods. The amendments are effective for all entities for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the requirement to disclose rollforward information, which is effective prospectively for fiscal years beginning after December 15, 2023. The Company adopted the standard on January 1, 2023 which resulted in additional disclosures. Refer to Note 13. Recent Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption on our consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosure which includes amendments that further expand income tax disclosures, by requiring the disaggregation of information in the rate reconciliation table, and income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and are to be applied either prospectively or retrospectively. The Company is currently evaluating the impact of adoption on the Company’s related disclosures. There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Sep. 30, 2024
Inventory Disclosure [Abstract]
Components of Inventories	Inventories consist of the following: September 30, December 31, 2024 2023 Raw materials and supplies $ 140.6 $ 137.5 Work in process 51.5 40.2 Finished goods 466.4 435.6 Total $ 658.5 $ 613.3

Property, Plant and Equipment_2

Property, Plant and Equipment, Net ("PP&E") (Tables)	9 Months Ended
Property, Plant and Equipment, Net ("PP&E") (Tables)	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	PP&E consists of the following: September 30, December 31, 2024 2023 Land $ 28.3 $ 28.3 Buildings and improvements 346.2 317.8 Machinery and equipment 987.8 895.1 Software 128.1 122.6 Office equipment and other assets 125.3 105.2 Construction in progress (1) 213.8 348.4 Gross PP&E 1,829.5 1,817.4 Less accumulated depreciation 914.2 889.7 Net PP&E $ 915.3 $ 927.7 (1) In connection with the Vitamins, Minerals and Supplements ("VMS") impairment review completed in the third quarter of 2024, the Company recorded an impairment charge of $ 60.0 in SG&A of Construction in progress assets. The charge was recorded in the Consumer Domestic segment. Refer to Note 11 for additional details. Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Depreciation expense on PP&E $ 21.0 $ 18.2 $ 59.8 $ 52.8

Earnings Per Share ("EPS") (Tab

Earnings Per Share ("EPS") (Tables)	9 Months Ended
Earnings Per Share ("EPS") (Tables)	Sep. 30, 2024
Earnings Per Share [Abstract]
Reconciliation Of Weighted Average Number Of Common Shares Outstanding	The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Weighted average common shares outstanding - basic 244.6 246.0 244.1 244.9 Dilutive effect of stock options 0.0 (1) 2.7 2.6 2.9 Weighted average common shares outstanding - diluted 244.6 248.7 246.7 247.8 Antidilutive stock options outstanding 1.1 2.5 1.1 2.6 (1) Due to the net loss during the three months ended September 30, 2024, there was no dilutive effect of stock options because the impact would be antidilutive.

Stock Based Compensation Plans

Stock Based Compensation Plans (Tables)	9 Months Ended
Stock Based Compensation Plans (Tables)	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Option Activity	The following table provides a summary of option activity: Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Term Intrinsic Options Price (per share) (in Years) Value Outstanding at December 31, 2023 10.2 $ 68.77 Granted 1.0 100.43 Exercised ( 1.7 ) 52.40 Cancelled ( 0.1 ) 86.15 Outstanding at September 30, 2024 9.4 $ 75.03 6.0 $ 281.4 Exercisable at September 30, 2024 6.0 $ 66.78 4.6 $ 226.9
Information Regarding Intrinsic Value of Stock Options Exercised and Stock Compensation Expense Related to Stock Option Awards	The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Intrinsic Value of Stock Options Exercised $ 5.3 $ 14.2 $ 86.6 $ 121.9 Stock Compensation Expense Related to Stock Option Awards $ 4.3 $ 3.8 $ 24.8 $ 22.7 Issued Stock Options 0.0 0.0 1.0 1.0 Weighted Average Fair Value of Stock Options issued (per share) $ 0.0 $ 0.0 $ 29.90 $ 24.05 Fair Value of Stock Options Issued $ 0.0 $ 0.0 $ 31.1 $ 24.8
Assumptions Used in Valuation of Issued Stock Options	The following table provides a summary of the assumptions used in the valuation of issued stock options: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Risk-free interest rate N/A N/A 4.2 % 4.0 % Expected life in years N/A N/A 7.2 7.3 Expected volatility N/A N/A 22.3 % 22.4 % Dividend yield N/A N/A 1.1 % 1.3 %

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Carrying Amounts and Estimated Fair Values of Other Financial Instruments	The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 Input Carrying Fair Carrying Fair Level Amount Value Amount Value Financial Assets: Cash equivalents Level 1 $ 571.9 $ 571.9 $ 217.7 $ 217.7 Financial Liabilities: Short-term borrowings Level 2 3.4 3.4 3.9 3.9 Term loan due December 22, 2024 Level 2 0.0 0.0 200.0 200.0 3.15 % Senior notes due August 1, 2027 Level 2 424.9 415.1 424.8 406.9 2.3 % Senior notes due December 15, 2031 Level 2 399.4 348.8 399.3 338.6 5.6 % Senior notes due November 15, 2032 Level 2 499.2 537.4 499.2 535.6 3.95 % Senior notes due August 1, 2047 Level 2 397.8 333.8 397.7 333.7 5.00 % Senior notes due June 15, 2052 Level 2 499.8 491.3 499.8 498.1 International long-term debt Level 2 4.2 4.2 0.0 0.0

Derivative Instruments and Ri_2

Derivative Instruments and Risk Management (Tables)	9 Months Ended
Derivative Instruments and Risk Management (Tables)	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts	The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table: Notional Notional Amount Amount September 30, 2024 December 31, 2023 Derivatives designated as hedging instruments Foreign exchange contracts $ 219.7 $ 228.9 Diesel fuel contracts 1.9 gallons 2.3 gallons Commodities contracts 10.4 pounds 59.0 pounds Derivatives not designated as hedging instruments Foreign exchange contracts $ 0.3 $ 0.0 Equity derivatives $ 24.5 $ 23.2

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
Acquisitions (Tables)	Sep. 30, 2024
Business Acquisition [Line Items]
Summary of Assets Acquired and Liabilities Assumed	The preliminary fair values of the net assets at acquisition are set forth as follows: Accounts receivable $ 3.5 Inventory 11.3 Other current assets 1.5 Other long-term assets 5.8 Customer relationship intangible asset 8.4 Goodwill 2.8 Accounts payable, accrued and other liabilities ( 6.9 ) Long-term debt ( 4.4 ) Deferred income taxes ( 2.1 ) Cash purchase price (net of cash acquired) $ 19.9
Fair Values of Assets Acquired	The fair values of the net assets at acquisition are set forth as follows: Accounts receivable $ 19.5 Inventory 25.4 Other current assets 1.2 Property, plant and equipment 0.4 Trade name 400.0 Other intangible assets 71.9 Goodwill 156.1 Accounts payable, accrued and other liabilities ( 1.1 ) Deferred and other long-term liabilities ( 1.4 ) Deferred income taxes ( 117.2 ) Business acquisition liabilities - long-term ( 8.0 ) Cash purchase price (net of cash acquired) $ 546.8

Goodwill and Other Intangible_2

Goodwill and Other Intangibles, Net (Tables)	9 Months Ended
Goodwill and Other Intangibles, Net (Tables)	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets With a Definite Life	The following table provides information related to the carrying value of intangible assets with a definite life: September 30, 2024 December 31, 2023 Gross Amortization Gross Carrying Accumulated Period Carrying Accumulated Amount Amortization Impairments (1) Net (Years) Amount Amortization Impairments Net Intangible assets with a definite life: Trade Names $ 1,384.5 $ ( 461.2 ) $ 0.0 $ 923.3 3 - 20 $ 1,385.5 $ ( 403.5 ) $ 0.0 $ 982.0 Customer Relationships 645.6 ( 395.2 ) ( 15.8 ) 234.6 15 - 20 644.9 ( 373.3 ) ( 3.5 ) 268.1 Patents/Formulas 205.6 ( 124.2 ) 0.0 81.4 4 - 20 208.3 ( 116.1 ) ( 1.9 ) 90.3 Total $ 2,235.7 $ ( 980.6 ) $ ( 15.8 ) $ 1,239.3 $ 2,238.7 $ ( 892.9 ) $ ( 5.4 ) $ 1,340.4 (1) Intangible asset impairment of VMS customer relationships. See Indefinite-Lived Trade Names disclosure for more info rmation.
Schedule of Indefinite-Lived Trade Names	The following table presents the carrying value of indefinite-lived trade names : September 30, December 31, 2024 2023 Gross Carrying Value Trade Names $ 1,961.7 $ 1,961.9 VMS impairment 281.3 0.0 Net Carrying Value Trade Names $ 1,680.4 $ 1,961.9
Carrying Amount of Goodwill	The carrying amount of goodwill is as follows: Consumer Consumer Specialty Domestic International Products Total Balance at December 31, 2023 $ 2,061.1 $ 234.4 $ 136.0 $ 2,431.5 Graphico acquired goodwill 0.0 $ 2.8 0.0 2.8 Passport divestiture 0.0 0.0 ( 1.0 ) ( 1.0 ) Balance at September 30, 2024 $ 2,061.1 $ 237.2 $ 135.0 $ 2,433.3
Intangible and Fixed Asset Impairment Charges	A summary of the VMS intangible and fixed asset impairment charges are as follows: September 30, 2024 Trade Name $ 281.3 Customer Relationship Intangible Asset 15.8 PP&E 60.0 Total VMS impairment charges $ 357.1

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Sep. 30, 2024
Leases [Abstract]
Summary of Lease Information	A summary of the Company’s lease information is as follows: September 30, December 31, Classification 2024 2023 Assets Right of use assets Other Assets $ 182.8 $ 186.0 Liabilities Current lease liabilities Accrued and Other Liabilities $ 30.4 $ 24.7 Long-term lease liabilities Deferred and Other Long-term Liabilities 170.9 174.9 Total lease liabilities $ 201.3 $ 199.6 Other information Weighted-average remaining lease term (years) 7.7 8.1 Weighted-average discount rate 4.6 % 4.5 % Three Months Three Months Nine Months Nine Months Ended Ended Ended Ended September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Statement of (Loss) Income Lease cost (1) $ 10.0 $ 7.9 $ 29.8 $ 23.5 Other information Leased assets obtained in exchange for new lease liabilities net of modifications (2) $ 1.2 $ 2.2 $ 19.6 $ 7.3 Cash paid for amounts included in the measurement of lease liabilities $ 8.7 $ 7.6 $ 25.0 $ 23.1 (1) Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first nine months of 2024 and 2023 wa s $ 22.8 and $ 17.9 , respectively, and is included in the Amortization caption in the condensed consolidated statement of cash flo ws. (2) In January 2024, the Company expanded space at one of its leased manufacturing facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $ 15.4 recorded in the first quarter of 2024.
Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements	The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows: Operating Leases 2024 $ 9.8 2025 38.4 2026 30.0 2027 28.1 2028 25.5 2029 and thereafter 109.4 Total future minimum lease commitments 241.2 Less: Imputed interest ( 39.9 ) Present value of lease liabilities $ 201.3

Accounts Payable Accrued and Ot

Accounts Payable Accrued and Other Liabilities (Tables)	9 Months Ended
Accounts Payable Accrued and Other Liabilities (Tables)	Sep. 30, 2024
Payables and Accruals [Abstract]
Accounts Payable and Accrued and other Liabilities	Accounts payable, accrued and other liabilities consist of the following: September 30, December 31, 2024 2023 Accounts payable $ 705.9 $ 630.6 Accrued marketing and promotion costs 249.5 276.7 Accrued wages and related benefit costs 116.5 152.3 Other accrued current liabilities 163.6 151.4 Total $ 1,235.5 $ 1,211.0

Short-Term Borrowings and Lon_2

Short-Term Borrowings and Long-Term Debt (Tables)	9 Months Ended
Short-Term Borrowings and Long-Term Debt (Tables)	Sep. 30, 2024
Debt Disclosure [Abstract]
Components of Short-Term Borrowings and Long-Term Debt	Short-term borrowings and long-term debt consist of the following: September 30, December 31, 2024 2023 Short-term borrowings Various debt due to international banks 3.4 3.9 Total short-term borrowings $ 3.4 $ 3.9 Long-term debt Term loan due December 22, 2024 $ 0.0 $ 200.0 3.15 % Senior notes due August 1, 2027 425.0 425.0 Less: Discount ( 0.1 ) ( 0.2 ) 2.3 % Senior notes due December 15, 2031 400.0 400.0 Less: Discount ( 0.6 ) ( 0.7 ) 5.6 % Senior notes due November 15, 2032 500.0 500.0 Less: Discount ( 0.8 ) ( 0.8 ) 3.95 % Senior notes due August 1, 2047 400.0 400.0 Less: Discount ( 2.2 ) ( 2.3 ) 5.00 % Senior notes due June 15, 2052 500.0 500.0 Less: Discount ( 0.2 ) ( 0.2 ) Various debt due to international banks 4.2 0.0 Debt issuance costs, net ( 17.1 ) ( 18.7 ) Total long-term debt 2,208.2 2,402.1 Less: Current maturities 0.0 ( 199.9 ) Net long-term debt $ 2,208.2 $ 2,202.2

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
Accumulated Other Comprehensive (Loss) Income (Tables)	Sep. 30, 2024
Equity [Abstract]
Components of Changes in Accumulated Other Comprehensive (Loss) Income	The components of changes in accumulated other comprehensive (loss) income are as follows: Accumulated Foreign Defined Other Currency Benefit Derivative Comprehensive Adjustments Plans Agreements Income (Loss) Balance at December 31, 2022 $ ( 46.4 ) $ 1.7 $ 15.4 $ ( 29.3 ) Other comprehensive (loss) income before reclassifications ( 0.7 ) 3.8 2.2 5.3 Amounts reclassified to condensed consolidated statement of (a) (b) 0.0 0.0 ( 5.0 ) ( 5.0 ) Tax benefit (expense) 0.0 ( 1.0 ) 0.6 ( 0.4 ) Other comprehensive (loss) income ( 0.7 ) 2.8 ( 2.2 ) ( 0.1 ) Balance at September 30, 2023 $ ( 47.1 ) $ 4.5 $ 13.2 $ ( 29.4 ) Balance at December 31, 2023 $ ( 37.8 ) $ 4.6 $ 6.0 $ ( 27.2 ) Other comprehensive income (loss) before reclassifications 5.3 ( 0.2 ) 7.3 12.4 Amounts reclassified to condensed consolidated statement of (a) (b) 0.0 0.0 ( 1.6 ) ( 1.6 ) Tax benefit (expense) 0.0 0.0 ( 1.8 ) ( 1.8 ) Other comprehensive (loss) income 5.3 ( 0.2 ) 3.9 9.0 Balance at September 30, 2024 $ ( 32.5 ) $ 4.4 $ 9.9 $ ( 18.2 ) (a) Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense. The Company reclassified a gain of $ 0.6 a nd a gain of $ 1.3 to the condensed consolidated statements of (loss) income during the three months ended September 30, 2024 and 2023, respectively.

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
Related Party Transactions (Tables)	Sep. 30, 2024
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following summarizes the balances and transactions between the Company and Armand Products Company (“Armand”) and the ArmaKleen Company (“ArmaKleen”). The Company held a 50 % ownership interest as of September 30, 2024 in each: Armand ArmaKleen (2) Nine Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Purchases by the Company $ 10.6 $ 11.7 $ 0.0 $ 0.0 Sales by the Company $ 0.0 $ 0.0 $ 1.0 $ 1.1 Outstanding Accounts Receivable $ 0.5 $ 0.6 $ 0.7 $ 0.7 Outstanding Accounts Payable $ 0.9 $ 1.3 $ 0.0 $ 0.0 Administration & Management Oversight Services (1) $ 1.7 $ 1.7 $ 1.6 $ 1.6 (1) Billed by the Company and recorded as a reduction of SG&A expenses . (2) In October 2024, the Company sold its 50 % interest in Armakleen to an unrelated third party. The transaction is not material to the Company's results of operations or cash flows.

Segments (Tables)

Segments (Tables)	9 Months Ended
Segments (Tables)	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Selected Financial Information Relating To Company's Segments	Segment net sales and income (loss) before income taxes are as follows: Consumer Consumer Domestic International SPD Corporate (3) Total Net Sales (1) Third Quarter 2024 $ 1,170.8 $ 267.7 $ 72.1 $ 0.0 $ 1,510.6 Third Quarter 2023 1,133.1 244.4 78.4 0.0 1,455.9 First Nine Months of 2024 $ 3,506.6 $ 786.4 $ 232.1 $ 0.0 $ 4,525.1 First Nine Months of 2023 3,378.2 716.9 244.8 0.0 4,339.9 (Loss) Income before Income Taxes (2) Third Quarter 2024 (4) $ ( 107.1 ) $ ( 4.7 ) $ 7.4 $ 3.0 $ ( 101.4 ) Third Quarter 2023 203.4 22.7 6.2 1.7 234.0 First Nine Months of 2024 (4) $ 405.3 $ 61.2 $ 29.5 $ 7.2 $ 503.2 First Nine Months of 2023 662.8 79.1 22.2 8.1 772.2 (1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $ 7.0 and $ 4.7 for the three months ended September 30, 2024 and September 30, 2023, respectively, and were $ 19.6 and $ 11.7 for the nine months ended September 30, 2024 and September 30, 2023, respectively. (2) In determining income (loss) before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income (loss) from operations. (3) The Corporate segment consists of equity in earnings of affiliates from Armand and ArmaKleen for the three and nine months ended Sep tember 30, 2024 and September 30, 2023. The Company's 50 % interest in Armakleen was sold to an unrelated third party in October of 2024. The transaction is not material to the Company’s results of operations or cash flows. (4) In the third quarter and first nine months of 2024, the results include the VMS non-cash intangible and PP&E impairment charges of $ 357.1 in SG&A expenses, of which $ 327.4 was recorded in the Consumer Domestic segment and $ 29.7 was recorded in the Consumer International seg ment.
Summary of Product Line Revenues From External Customers	Product line revenues from external customers are as follows: Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2024 2023 2024 2023 Household Products $ 637.4 $ 636.2 $ 1,929.5 $ 1,857.0 Personal Care Products 533.4 496.9 1,577.1 1,521.2 Total Consumer Domestic 1,170.8 1,133.1 3,506.6 3,378.2 Total Consumer International 267.7 244.4 786.4 716.9 Total SPD 72.1 78.4 232.1 244.8 Total Consolidated Net Sales $ 1,510.6 $ 1,455.9 $ 4,525.1 $ 4,339.9

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Research and development expenses	$ 36	$ 30.3	$ 99.1	$ 87.2

Inventories Components of Inven

Inventories Components of Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Inventory, Finished Goods and Work in Process, Net of Reserves [Abstract]
Raw materials and supplies	$ 140.6	$ 137.5
Work in process	51.5	40.2
Finished goods	466.4	435.6
Total	$ 658.5	$ 613.3

Property, Plant and Equipment_3

Property, Plant and Equipment, Net ("PP&E") - Components of Property, Plant and Equipment (Details) - USD ($) $ in Millions		Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Gross PP&E		$ 1,829.5	$ 1,817.4
Less accumulated depreciation and amortization		914.2	889.7
Net PP&E		915.3	927.7
Land
Property, Plant and Equipment [Line Items]
Gross PP&E		28.3	28.3
Buildings and improvements
Property, Plant and Equipment [Line Items]
Gross PP&E		346.2	317.8
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Gross PP&E		987.8	895.1
Software
Property, Plant and Equipment [Line Items]
Gross PP&E		128.1	122.6
Office equipment and other assets
Property, Plant and Equipment [Line Items]
Gross PP&E		125.3	105.2
Construction in progress
Property, Plant and Equipment [Line Items]
Gross PP&E	[1]	$ 213.8	$ 348.4

[1] (1) In connection with the Vitamins, Minerals and Supplements ("VMS") impairment review completed in the third quarter of 2024, the Company recorded an impairment charge of $ 60.0 in SG&A of Construction in progress assets. The charge was recorded in the Consumer Domestic segment. Refer to Note 11 for additional details.

Property, Plant and Equipment_4

Property, Plant and Equipment, Net ("PP&E") - Components of Property, Plant and Equipment (Parenthetical) (Details)	9 Months Ended
	Sep. 30, 2024 USD ($)
Construction in progress
Property, Plant and Equipment [Line Items]
Impairment charge	$ 60

Property, Plant and Equipment_5

Property, Plant and Equipment, Net ("PP&E") - Depreciation and Interest Charges on Property, Plant and Equipment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense on PP&E	$ 21	$ 18.2	$ 59.8	$ 52.8

Earnings Per Share (EPS) - Reco

Earnings Per Share (EPS) - Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding (Details) - shares shares in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2024		Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Weighted average shares outstanding - Basic	244.6		246	244.1	244.9
Dilutive effect of stock options	0	[1]	2.7	2.6	2.9
Weighted average common shares outstanding - diluted	244.6		248.7	246.7	247.8
Antidilutive stock options outstanding	1.1		2.5	1.1	2.6

[1] (1) Due to the net loss during the three months ended September 30, 2024, there was no dilutive effect of stock options because the impact would be antidilutive.

Earnings Per Share (EPS) - Re_2

Earnings Per Share (EPS) - Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding (Parenthetical) (Details) $ in Millions	3 Months Ended
	Sep. 30, 2024 USD ($)
Earnings Per Share [Abstract]
Dilutive effect of stock options	$ 0

Stock Based Compensation Plan_2

Stock Based Compensation Plans - Summary of Option Activity (Details) $ / shares in Units, shares in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Beginning Balance, Options \| shares	10.2
Granted, Options \| shares	1
Exercised, Options \| shares	(1.7)
Cancelled, Options \| shares	(0.1)
Ending Balance, Options \| shares	9.4
Exercisable September 30, 2024 \| shares	6
Beginning Balance, Weighted-Average Exercise Price \| $ / shares	$ 68.77
Granted, Weighted-Average Exercise Price \| $ / shares	100.43
Exercised, Weighted-Average Exercise Price \| $ / shares	52.4
Cancelled, Weighted-Average Exercise Price \| $ / shares	86.15
Ending Balance, Weighted-Average Exercise Price \| $ / shares	75.03
Exercisable at September 30, 2024 Weighted-Average Exercise Price \| $ / shares	$ 66.78
Outstanding at September 30, 2024, Weighted-Average Remaining Contractual Term, years	6 years
Exercisable at September 30, 2024, Weighted-Average Remaining Contractual Term, years	4 years 7 months 6 days
Outstanding at September 30, 2024, Aggregate Intrinsic Value \| $	$ 281.4
Exercisable at September 30, 2024, Aggregate Intrinsic Value \| $	$ 226.9

Stock Based Compensation Plan_3

Stock Based Compensation Plans - Schedule of Share Based Compensation Stock Options (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Intrinsic Value of Stock Options Exercised	$ 5.3	$ 14.2	$ 86.6	$ 121.9
Stock Compensation Expense Related to Stock Option Awards	$ 4.3	$ 3.8	$ 24.8	$ 22.7
Issued Stock Options	0	0	1	1
Weighted Average Fair Value of Stock Options issued (per share)	$ 0	$ 0	$ 29.9	$ 24.05
Fair Value of Stock Options Issued	$ 0	$ 0	$ 31.1	$ 24.8

Stock Based Compensation Plan_4

Stock Based Compensation Plans - Assumptions Used in Valuation of Issued Stock Options (Details)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Risk-free interest rate	4.20%	4%
Expected life in years	7 years 2 months 12 days	7 years 2 months 12 days
Expected volatility	22.30%	22.40%
Dividend yield	1.10%	1.30%

Stock Based Compensation Plan_5

Stock Based Compensation Plans (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	9 Months Ended
	Oct. 01, 2022	Oct. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Common Stock, shares issued			293,709,982		293,709,982
Hero Acquisition Member
Vesting shares		213,719	213,719
Restricted Stock Units (RSUs) [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross	854,882		105,600	119,570
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 61.5		$ 10.8	$ 10.3
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 101.93	$ 86.18
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period	3 years
Restricted Stock Units (RSUs) [Member] \| Hero Acquisition Member
Vesting shares		213,719	213,719
Restricted Stock or Unit Expense			$ 17.2	$ 21.9
Performance Stock Units (PSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 122.24	$ 110.95
Common Stock, shares issued			19,960	19,650
Performance Stock Units (PSUs) [Member] \| Minimum [Member]
Performance stock issued range			0%
Performance Stock Units (PSUs) [Member] \| Maximum [Member]
Performance stock issued range				200%

Share Repurchases - Additional

Share Repurchases - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2024	Oct. 28, 2021
Accelerated Share Repurchases [Line Items]
Stock repurchase program remaining authorized repurchase amount		$ 1,000
Commercial Bank
Accelerated Share Repurchases [Line Items]
Stock repurchase program remaining authorized repurchase amount	$ 658.9

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Short-term borrowings	$ 3.4	$ 3.9
Senior Notes	2,208.2	2,402.1
Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents	571.9	217.7
Short-term borrowings	3.4	3.9
Fair Value \| Fair Value, Inputs, Level 1
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents	571.9	217.7
Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Short-term borrowings	3.4	3.9
Senior notes	491.3	498.1
Term Loan Due December 22, 2024 \| Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	0	200
Term Loan Due December 22, 2024 \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	0	200
3.15% Senior notes due August 1, 2027 \| Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	424.9	424.8
3.15% Senior notes due August 1, 2027 \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	415.1	406.9
2.3% Senior notes due December 15, 2031 \| Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	399.4	399.3
2.3% Senior notes due December 15, 2031 \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	348.8	338.6
5.6% Senior notes due November 15, 2032 \| Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	499.2	499.2
5.6% Senior notes due November 15, 2032 \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	537.4	535.6
3.95% Senior notes due August 1, 2047 \| Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	397.8	397.7
3.95% Senior notes due August 1, 2047 \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	333.8	333.7
5.00% Senior notes due June 15, 2052 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	499.8	499.8
International long-Term Debt [Member] \| Carrying Amount \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	4.2	0
International long-Term Debt [Member] \| Fair Value \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	$ 4.2	$ 0

Fair Value Measurements - Car_2

Fair Value Measurements - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Parenthetical) (Details)	Sep. 30, 2024	Dec. 31, 2023
3.15% Senior notes due August 1, 2027
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.15%	3.15%
3.15% Senior notes due August 1, 2027 \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.15%	3.15%
2.3% Senior notes due December 15, 2031
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	2.30%	2.30%
2.3% Senior notes due December 15, 2031 \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	2.30%	2.30%
3.95% Senior notes due August 1, 2047
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.95%	3.95%
3.95% Senior notes due August 1, 2047 \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.95%	3.95%
5.00% Senior notes due June 15, 2052 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	5%	5%
5.00% Senior notes due June 15, 2052 [Member] \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	5%	5%
5.6% Senior notes due November 15, 2032
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	5.60%	5.60%
5.6% Senior notes due November 15, 2032 \| Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	5.60%	5.60%

Derivative Instruments and Ri_3

Derivative Instruments and Risk Management - Schedule of Notional Amounts (Details) lb in Millions, gal in Millions, $ in Millions	Sep. 30, 2024 USD ($) lb gal	Dec. 31, 2023 USD ($) lb gal
Designated as Hedging Instrument \| Foreign Exchange Contract
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount	$ 219.7	$ 228.9
Designated as Hedging Instrument \| Diesel fuel contracts
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount, Volume \| gal	1.9	2.3
Designated as Hedging Instrument \| Commodities Contracts
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount, Volume \| lb	10.4	59
Not Designated as Hedging Instrument \| Foreign Exchange Contract
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount	$ 0.3	$ 0
Not Designated as Hedging Instrument \| Equity derivatives
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount	$ 24.5	$ 23.2

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ in Millions			1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Jun. 03, 2024	Oct. 13, 2022	Oct. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2024
Business Acquisition [Line Items]
Net Sales				$ 1,510.6	$ 1,455.9		$ 4,525.1	$ 4,339.9
Graphico Acquisition [Member]
Business Acquisition [Line Items]
Closing payment of net of cash acquired				19.9			19.9				$ 19.9
Net Sales									$ 38
Average life of the intangible assets, years	15 years
Business Combination Cash Purchase Price Net Of Contingent Consideration				19.9			19.9				$ 19.9
Acquisitions minority shares	$ 2
Hero Acquisition Member
Business Acquisition [Line Items]
Closing payment of net of cash acquired		$ 546.8		546.8			$ 546.8
Additional cash payment		8
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 61.5
Vesting shares			213,719				213,719
Business acquisition, period		5 years
Net Sales										$ 179
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred						$ 3.5
Business Combination Cash Purchase Price Net Of Contingent Consideration		$ 546.8		546.8			$ 546.8
Deferred and other long-term liabilities				$ 1.4			$ 1.4
Hero Acquisition Member \| Maximum
Business Acquisition [Line Items]
Average life of the intangible assets, years							20 years
Hero Acquisition Member \| Minimum
Business Acquisition [Line Items]
Average life of the intangible assets, years							10 years

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Fair Values of Net Asses (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 2,433.3		$ 2,431.5
Graphico Acquisition [Member]
Business Acquisition [Line Items]
Accounts receivable	3.5
Inventory	11.3
Other current assets	1.5
Other long-term assets	5.8
Customer relationship intangible asset	8.4
Goodwill	2.8
Accounts payable, accrued and other liabilities	(6.9)
Long-term debt	(4.4)
Deferred income taxes	(2.1)
Cash purchase price (net of cash acquired)	$ 19.9	$ 19.9

Acquisitions - Schedule of Fair

Acquisitions - Schedule of Fair Values of Net Assets Acquired (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Oct. 13, 2022
Business Acquisition [Line Items]
Goodwill	$ 2,433.3	$ 2,431.5
Hero Acquisition Member
Business Acquisition [Line Items]
Accounts receivable	19.5
Inventory	25.4
Other current assets	1.2
Property, plant and equipment	0.4
Trade name	400
Other intangible assets	71.9
Goodwill	156.1
Accounts payable, accrued and other liabilities	(1.1)
Deferred and other long-term liabilities	(1.4)
Deferred income taxes	(117.2)
Business acquisition liabilities - long-term	(8)
Cash purchase price (net of cash acquired)	$ 546.8		$ 546.8

Goodwill and Other Intangible_3

Goodwill and Other Intangibles, Net - Summary of Intangible Assets With a Definite Life (Details) - USD ($) $ in Millions	9 Months Ended		12 Months Ended
	Sep. 30, 2024		Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,235.7		$ 2,238.7
Accumulated Amortization	(980.6)		(892.9)
Impairments	(15.8)	[1]	(5.4)
Net	1,239.3		1,340.4
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,384.5		1,385.5
Accumulated Amortization	(461.2)		(403.5)
Impairments	0	[1]	0
Net	$ 923.3		982
Trade Name [Member] \| Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	3 years
Trade Name [Member] \| Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	20 years
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 645.6		644.9
Accumulated Amortization	(395.2)		(373.3)
Impairments	(15.8)	[1]	(3.5)
Net	$ 234.6		268.1
Customer Relationships [Member] \| Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	15 years
Customer Relationships [Member] \| Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	20 years
Patents/Formulas
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 205.6		208.3
Accumulated Amortization	(124.2)		(116.1)
Impairments	0	[1]	(1.9)
Net	$ 81.4		$ 90.3
Patents/Formulas \| Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	4 years
Patents/Formulas \| Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	20 years

[1] Intangible asset impairment of VMS customer relationships. See Indefinite-Lived Trade Names disclosure for more info rmation.

Goodwill and Other Intangible_4

Goodwill and Other Intangibles, Net - Summary of Indefinite-Lived Trade Names (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Indefinite-lived Intangible Assets [Line Items]
VMS impairment	$ 281.3	$ 0
Net Carrying Value Trade Names	2,919.7	3,302.3
Trade Name [Member]
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Value Trade Names	1,961.7	1,961.9
Net Carrying Value Trade Names	$ 1,680.4	$ 1,961.9

Goodwill and Other Intangible_5

Goodwill and Other Intangibles, Net - Summary of VMS Intangible and Fixed Asset Impairment Charges (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Indefinite-Lived Intangible Assets [Line Items]
Intangible and Fixed Asset Impairment Charges	$ 357.1
Property Plant and Equipment [Member]
Indefinite-Lived Intangible Assets [Line Items]
Intangible and Fixed Asset Impairment Charges	60
Customer Relationship Intangible Asset [Member]
Indefinite-Lived Intangible Assets [Line Items]
Intangible and Fixed Asset Impairment Charges	15.8
Trade Name [Member]
Indefinite-Lived Intangible Assets [Line Items]
Intangible and Fixed Asset Impairment Charges	$ 281.3

Goodwill and Other Intangible_6

Goodwill and Other Intangibles, Net - Summary of Carrying Amount of Goodwill (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Goodwill [Line Items]
Beginning balance	$ 2,431.5
Ending balance	2,433.3
Hero Acquisition [Member]
Goodwill [Line Items]
Ending balance	156.1
Graphico [Member]]
Goodwill [Line Items]
Acquired goodwill	2.8
Passport Divestiture [Member]
Goodwill [Line Items]
Written off related to sale	(1)
Consumer Domestic
Goodwill [Line Items]
Beginning balance	2,061.1
Ending balance	2,061.1
Consumer Domestic \| Graphico [Member]]
Goodwill [Line Items]
Acquired goodwill	0
Consumer Domestic \| Passport Divestiture [Member]
Goodwill [Line Items]
Written off related to sale	0
Consumer International
Goodwill [Line Items]
Beginning balance	234.4
Ending balance	237.2
Consumer International \| Graphico [Member]]
Goodwill [Line Items]
Acquired goodwill	2.8
Consumer International \| Passport Divestiture [Member]
Goodwill [Line Items]
Written off related to sale	0
Specialty Products
Goodwill [Line Items]
Beginning balance	136
Ending balance	135
Specialty Products \| Graphico [Member]]
Goodwill [Line Items]
Acquired goodwill	0
Specialty Products \| Passport Divestiture [Member]
Goodwill [Line Items]
Written off related to sale	$ (1)

Goodwill and Other Intangible_7

Goodwill and Other Intangibles, Net - Additional Information (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
	Oct. 01, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Amortization expense of intangible assets		$ 30.7	$ 31.1	$ 92.2	$ 93.3
Finite lived intangible assets amortization expense current year estimate		117		117
Pre-Tax Impairment Charge		75.8		75.8
Property, Plant and Equipment, Net		915.3		915.3		$ 927.7
Impairment charge				357.1
Fair Value Exceeded Carrying Value	109%
Property Plant and Equipment [Member]
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Property, Plant and Equipment, Net		140		140
Impairment charge				$ 60
WATERPIK [Member]
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Discount on estimated future cashflow	8.80%
Trade Name [Member]
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Discount on estimated future cashflow				8.25%
Indefinite lived trade names	$ 644.7	0		$ 0
Impairment charge				$ 281.3
Customer Relationship Intangible Asset [Member]
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Discount on estimated future cashflow				8.25%
Indefinite lived trade names		0		$ 0
Impairment charge				15.8
Maximum
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Estimated amortization expense, 2026		$ 116		$ 116
Maximum \| Trade Name [Member]
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Amortization Period (Years)		20 years		20 years
Minimum
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Estimated amortization expense, 2026		$ 88		$ 88
Minimum \| Trade Name [Member]
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Amortization Period (Years)		3 years		3 years

Leases - Summary of Lease infor

Leases - Summary of Lease information (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Leases [Abstract]
Right of use assets		$ 182.8		$ 182.8		$ 186
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]		Other Assets, Noncurrent		Other Assets, Noncurrent		Other Assets, Noncurrent
Current lease liabilities		$ 30.4		$ 30.4		$ 24.7
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]		Accrued expenses and other liabilities		Accrued expenses and other liabilities		Accrued expenses and other liabilities
Long-term lease liabilities		$ 170.9		$ 170.9		$ 174.9
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]		Other Liabilities, Noncurrent		Other Liabilities, Noncurrent		Other Liabilities, Noncurrent
Total lease liabilities		$ 201.3		$ 201.3		$ 199.6
Weighted-average remaining lease term (years)		7 years 8 months 12 days		7 years 8 months 12 days		8 years 1 month 6 days
Weighted-average discount rate		4.60%		4.60%		4.50%
Lease cost	[1]	$ 10	$ 7.9	$ 29.8	$ 23.5
Leased assets obtained in exchange for new lease liabilities net of modifications	[2]	1.2	2.2	19.6	7.3
Cash paid for amounts included in the measurement of lease liabilities		$ 8.7	$ 7.6	$ 25	$ 23.1

[1] Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first nine months of 2024 and 2023 wa s $ 22.8 and $ 17.9 , respectively, and is included in the Amortization caption in the condensed consolidated statement of cash flo ws. In January 2024, the Company expanded space at one of its leased manufacturing facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $ 15.4 recorded in the first quarter of 2024.

Leases - Summary of Lease inf_2

Leases - Summary of Lease information (Parenthetical) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Non-cash component of lease expense	$ 22.8	$ 17.9
Increase (decrease) in right-of-use asset	$ 15.4

Leases - Summary of Minimum Ann

Leases - Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Operating Leases
2024	$ 9.8
2025	38.4
2026	30
2027	28.1
2028	25.5
2029 and thereafter	109.4
Total future minimum lease commitments	241.2
Less: Imputed interest	(39.9)
Present value of lease liabilities	$ 201.3	$ 199.6

Accounts Payable, Accrued and_2

Accounts Payable, Accrued and Other Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Accounts Payable and Accrued Liabilities, Current [Abstract]
Trade accounts payable	$ 705.9	$ 630.6
Accrued marketing and promotion costs	249.5	276.7
Accrued wages and related benefit costs	116.5	152.3
Other accrued current liabilities	163.6	151.4
Total	$ 1,235.5	$ 1,211

Accounts Payable, Accrued and_3

Accounts Payable, Accrued and Other Liabilities (Additional Information) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Payables and Accruals [Abstract]
Supply Chain Finance Program Outstanding Obligations	$ 86.5
Supply Chain Financing payments included in operating activities within the Company's Consolidated Statements of Cash Flows	$ 292.3

Summary of Short-Term Borrowing

Summary of Short-Term Borrowings and Long-Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Short-term borrowings
Various debt due to international banks	$ 3.4	$ 3.9
Total short-term borrowings	3.4	3.9
Long-term debt
Various debt due to international banks	4.2	0
Debt issuance costs, net	(17.1)	(18.7)
Long-term Debt, Total	2,208.2	2,402.1
Less: Current maturities	0	(199.9)
Net long-term debt	2,208.2	2,202.2
Term Loan Due December 22, 2024
Long-term debt
Senior notes	0	200
Senior Notes	0	200
3.15% Senior notes due August 1, 2027
Long-term debt
Senior notes	425	425
Less: Discount	(0.1)	(0.2)
Senior Notes	425	425
2.3% Senior notes due December 15, 2031
Long-term debt
Senior notes	400	400
Less: Discount	(0.6)	(0.7)
Senior Notes	400	400
5.6% Senior notes due November 15, 2032
Long-term debt
Senior notes	500	500
Less: Discount	(0.8)	(0.8)
Senior Notes	500	500
3.95% Senior notes due August 1, 2047
Long-term debt
Senior notes	400	400
Less: Discount	(2.2)	(2.3)
Senior Notes	400	400
Five Point Zero Zero Percentage Notes Due June Fifteen Two Thousand Fifty Two [Member]
Long-term debt
Senior notes	500	500
Less: Discount	(0.2)	(0.2)
Senior Notes	$ 500	$ 500

Summary of Short-Term Borrowi_2

Summary of Short-Term Borrowings and Long-Term Debt (Parenthetical) (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
3.15% Senior notes due August 1, 2027
Debt Instrument [Line Items]
Interest rate of debt	3.15%	3.15%
Maturity date of debt	Aug. 01, 2027	Aug. 01, 2027
2.3% Senior notes due December 15, 2031
Debt Instrument [Line Items]
Interest rate of debt	2.30%	2.30%
Maturity date of debt	Dec. 15, 2031	Dec. 15, 2031
5.6% Senior notes due November 15, 2032
Debt Instrument [Line Items]
Interest rate of debt	5.60%	5.60%
Maturity date of debt	Nov. 15, 2032	Nov. 15, 2032
3.95% Senior notes due August 1, 2047
Debt Instrument [Line Items]
Interest rate of debt	3.95%	3.95%
Maturity date of debt	Aug. 01, 2047	Aug. 01, 2047
5.00% Senior notes due June 15, 2052
Debt Instrument [Line Items]
Interest rate of debt	5%	5%
Maturity date of debt	Jun. 15, 2052	Jun. 15, 2052

Components of Changes in Accumu

Components of Changes in Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		$ (27.2)	$ (29.3)
Other comprehensive (loss) income before reclassifications		12.4	5.3
Amounts reclassified to condensed consolidated statement of (loss) income	[1],[2]	(1.6)	(5)
Tax benefit (expense)		(1.8)	(0.4)
Other comprehensive (loss) income		9	(0.1)
Ending balance		(18.2)	(29.4)
Foreign Currency Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		(37.8)	(46.4)
Other comprehensive (loss) income before reclassifications		5.3	(0.7)
Amounts reclassified to condensed consolidated statement of (loss) income	[1],[2]	0	0
Tax benefit (expense)		0	0
Other comprehensive (loss) income		5.3	(0.7)
Ending balance		(32.5)	(47.1)
Defined Benefit Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		4.6	1.7
Other comprehensive (loss) income before reclassifications		(0.2)	3.8
Amounts reclassified to condensed consolidated statement of (loss) income	[1],[2]	0	0
Tax benefit (expense)		0	(1)
Other comprehensive (loss) income		(0.2)	2.8
Ending balance		4.4	4.5
Derivative Agreements
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		6	15.4
Other comprehensive (loss) income before reclassifications		7.3	2.2
Amounts reclassified to condensed consolidated statement of (loss) income	[1],[2]	(1.6)	(5)
Tax benefit (expense)		(1.8)	0.6
Other comprehensive (loss) income		3.9	(2.2)
Ending balance		$ 9.9	$ 13.2

[1] Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense. The Company reclassified a gain of $ 0.6 a nd a gain of $ 1.3 to the condensed consolidated statements of (loss) income during the three months ended September 30, 2024 and 2023, respectively.

Components of Changes in Accu_2

Components of Changes in Accumulated Other Comprehensive (Loss) Income (Parenthetical) (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Foreign Currency Gain (Loss) Reclassified to Earnings, Net	$ 0.6	$ 1.3

Commitments, Contingencies an_2

Commitments, Contingencies and Guarantees - Additional Information (Details) $ in Millions				9 Months Ended
	Oct. 13, 2022 USD ($)	Dec. 24, 2021 USD ($)	Dec. 01, 2020 USD ($)	Sep. 30, 2024 USD ($) Tons	Dec. 31, 2023 USD ($)
Commitments And Contingencies Disclosure [Line Items]
Annual purchase commitment, in tons \| Tons				240,000
Commitments				$ 408.6
Outstanding guarantees and letters of credit				6
Business Acquisition Additional Cash Payable First Installment					$ 2
Business acquisition additional cash payable second installment				7
Business acquisition remaining cash payable installment				$ 5
Zicam Acquisition
Commitments And Contingencies Disclosure [Line Items]
Additional cash payment			$ 20
Business acquisition, period			5 years
Thera Breath Acquisition
Commitments And Contingencies Disclosure [Line Items]
Additional cash payment		$ 14
Hero Acquisition Member
Commitments And Contingencies Disclosure [Line Items]
Additional cash payment	$ 8
Business acquisition, period	5 years
Minimum \| Thera Breath Acquisition
Commitments And Contingencies Disclosure [Line Items]
Business acquisition, period		2 years
Maximum \| Thera Breath Acquisition
Commitments And Contingencies Disclosure [Line Items]
Business acquisition, period		4 years

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details)	Sep. 30, 2024	Sep. 30, 2023
Armand Products Company
Schedule of Equity Method Investments [Line Items]
Percentage of ownership interest	50%	50%
ArmaKleen Company
Schedule of Equity Method Investments [Line Items]
Percentage of ownership interest	50%	50%

Related Party Transactions - Ba

Related Party Transactions - Balances and Transactions Between the Company (Details) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Armand Products Company
Related Party Transaction [Line Items]
Purchases by Company		$ 10.6	$ 11.7
Sales by the Company		0	0
Outstanding Accounts Receivable		0.5	0.6
Outstanding Accounts Payable		0.9	1.3
Administration & Management Oversight Services	[1]	1.7	1.7
ArmaKleen Company
Related Party Transaction [Line Items]
Purchases by Company	[2]	0	0
Sales by the Company	[2]	1	1.1
Outstanding Accounts Receivable	[2]	0.7	0.7
Outstanding Accounts Payable	[2]	0	0
Administration & Management Oversight Services	[1],[2]	$ 1.6	$ 1.6

[1] Billed by the Company and recorded as a reduction of SG&A expenses In October 2024, the Company sold its 50 % interest in Armakleen to an unrelated third party. The transaction is not material to the Company's results of operations or cash flows.

Related Party Transactions - _2

Related Party Transactions - balances and transactions between the Company (Parenthetical) (Details)	1 Months Ended
	Oct. 31, 2024
Arma Kleen Company [Member] \| Subsequent Event [Member]
Related Party Transaction [Line Items]
Company sale interest	50%

Segments - Additional Informati

Segments - Additional Information (Details) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
Segments - Additional Information (Details) $ in Millions	Oct. 31, 2024	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) Segment	Sep. 30, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments \| Segment				3
Equity in earnings of affiliates		$ 3	$ 1.7	$ 7.2	$ 8.1
Armand Products Company
Segment Reporting Information [Line Items]
Percentage of ownership interest		50%	50%	50%	50%
ArmaKleen Company
Segment Reporting Information [Line Items]
Percentage of ownership interest		50%	50%	50%	50%
ArmaKleen Company \| Subsequent Event [Member]
Segment Reporting Information [Line Items]
Company sale interest	50%
Armand Products Company and ArmaKleen Company
Segment Reporting Information [Line Items]
Equity in earnings of affiliates		$ 3	$ 1.7	$ 7.2	$ 8.1

Segments - Summary of Segment n

Segments - Summary of Segment net sales and income before income taxes (Details) - USD ($) $ in Millions		3 Months Ended			9 Months Ended
		Sep. 30, 2024		Sep. 30, 2023	Sep. 30, 2024		Sep. 30, 2023
Segment Reporting Information [Line Items]
Net Sales		$ 1,510.6		$ 1,455.9	$ 4,525.1		$ 4,339.9
(Loss) Income before Income Taxes		(101.4)		234	503.2		772.2
Operating Segments
Segment Reporting Information [Line Items]
Net Sales	[1]	1,510.6		1,455.9	4,525.1		4,339.9
(Loss) Income before Income Taxes	[2]	(101.4)	[3]	234	503.2	[3]	772.2
Operating Segments \| Consumer Domestic
Segment Reporting Information [Line Items]
Net Sales	[1]	1,170.8		1,133.1	3,506.6		3,378.2
(Loss) Income before Income Taxes	[2]	(107.1)	[3]	203.4	405.3	[3]	662.8
Operating Segments \| Consumer International
Segment Reporting Information [Line Items]
Net Sales	[1]	267.7		244.4	786.4		716.9
(Loss) Income before Income Taxes	[2]	(4.7)	[3]	22.7	61.2	[3]	79.1
Operating Segments \| Specialty Products
Segment Reporting Information [Line Items]
Net Sales	[1]	72.1		78.4	232.1		244.8
(Loss) Income before Income Taxes	[2]	7.4	[3]	6.2	29.5	[3]	22.2
Corporate
Segment Reporting Information [Line Items]
Net Sales	[1],[4]	0		0	0		0
(Loss) Income before Income Taxes	[2],[4]	$ 3	[3]	$ 1.7	$ 7.2	[3]	$ 8.1

[1] Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $ 7.0 and $ 4.7 for the three months ended September 30, 2024 and September 30, 2023, respectively, and were $ 19.6 and $ 11.7 for the nine months ended September 30, 2024 and September 30, 2023, respectively. In determining income (loss) before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income (loss) from operations. In the third quarter and first nine months of 2024, the results include the VMS non-cash intangible and PP&E impairment charges of $ 357.1 in SG&A expenses, of which $ 327.4 was recorded in the Consumer Domestic segment and $ 29.7 was recorded in the Consumer International seg ment. The Corporate segment consists of equity in earnings of affiliates from Armand and ArmaKleen for the three and nine months ended Sep tember 30, 2024 and September 30, 2023. The Company's 50 % interest in Armakleen was sold to an unrelated third party in October of 2024. The transaction is not material to the Company’s results of operations or cash flows.

Segments - Summary of Segment_2

Segments - Summary of Segment net sales and income before income taxes (Parenthetical) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 1,510.6	$ 1,455.9	$ 4,525.1	$ 4,339.9
Asset Impairment Charges				357.1
Selling General and Administrative Expenses
Segment Reporting Information [Line Items]
Asset Impairment Charges		357.1		357.1
Consumer Domestic \| Selling General and Administrative Expenses
Segment Reporting Information [Line Items]
Asset Impairment Charges		327.4		327.4
Consumer International \| Selling General and Administrative Expenses
Segment Reporting Information [Line Items]
Asset Impairment Charges		29.7		29.7
Subsequent Event [Member] \| Arma Kleen Company [Member]
Segment Reporting Information [Line Items]
Company sale interest	50%
Intersegment Sales
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 7	$ 4.7	$ 19.6	$ 11.7

Segments - Summary of Product L

Segments - Summary of Product Line Revenues from External Customers (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net Sales		$ 1,510.6	$ 1,455.9	$ 4,525.1	$ 4,339.9
Operating Segments
Segment Reporting Information [Line Items]
Net Sales	[1]	1,510.6	1,455.9	4,525.1	4,339.9
Operating Segments \| Consumer Domestic
Segment Reporting Information [Line Items]
Net Sales	[1]	1,170.8	1,133.1	3,506.6	3,378.2
Operating Segments \| Consumer Domestic \| Household Products
Segment Reporting Information [Line Items]
Net Sales		637.4	636.2	1,929.5	1,857
Operating Segments \| Consumer Domestic \| Personal Care Products
Segment Reporting Information [Line Items]
Net Sales		533.4	496.9	1,577.1	1,521.2
Operating Segments \| Consumer International
Segment Reporting Information [Line Items]
Net Sales	[1]	267.7	244.4	786.4	716.9
Operating Segments \| Specialty Products
Segment Reporting Information [Line Items]
Net Sales	[1]	$ 72.1	$ 78.4	$ 232.1	$ 244.8

[1] Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $ 7.0 and $ 4.7 for the three months ended September 30, 2024 and September 30, 2023, respectively, and were $ 19.6 and $ 11.7 for the nine months ended September 30, 2024 and September 30, 2023, respectively.